1,702 results match your criteria: "Abbott Northwestern Hospital.[Affiliation]"

Background: In metastatic colorectal cancer (mCRC), improvements in survival from combining leucovorin/fluorouracil/oxaliplatin/irinotecan (FOLFOXIRI) with bevacizumab have come at the risk of increased rates of high-grade toxicities. Trilaciclib is indicated to decrease the incidence of chemotherapy-induced myelosuppression in patients receiving standard-of-care chemotherapy for extensive-stage small cell lung cancer.

Methods: Patients with untreated mCRC were randomly assigned 1:1 to trilaciclib (n = 164) or placebo (n = 162) prior to FOLFOXIRI/bevacizumab for up to 12 cycles (induction), followed by trilaciclib or placebo prior to fluorouracil/leucovorin/bevacizumab (maintenance).

View Article and Find Full Text PDF

Left Main Coronary CT-Guided Percutaneous Coronary Intervention: Role of Virtual Planning and Wireless Physiology.

JACC Cardiovasc Interv

December 2024

Center for Coronary Artery Disease, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA; Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA. Electronic address:

View Article and Find Full Text PDF

Outpatient Point-of-Care Ultrasound.

Med Clin North Am

January 2025

Novant Health Family Medicine Residency Program, Novant Health, Cornelius, NC 2803, USA.

The most commonly used outpatient primary care point-of-care ultrasound (POCUS) applications are similar to those used in the inpatient setting (eg, cardiac, pulmonary, and abdominal ultrasound). However, there are several additional POCUS applications that are highly applicable to the outpatient setting and should be considered for use by primary care practitioners. This article reviews 3 outpatient POCUS applications and their potential role in the primary care setting.

View Article and Find Full Text PDF

Update on the diagnosis and treatment of coronary complications of percutaneous coronary interventions.

J Invasive Cardiol

November 2024

Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota. Email:

Prevention, prompt diagnosis, and rapid treatment are crucial for improving outcomes of complications that occur during percutaneous coronary intervention (PCI). The authors summarize studies on PCI complications published between January 1, 2023, and May 1, 2024, including coronary dissection, no reflow, perforation, and equipment loss/entrapment.

View Article and Find Full Text PDF

Outcomes of Left Main Chronic Total Occlusion Percutaneous Coronary Interventions.

Catheter Cardiovasc Interv

January 2025

Center for Coronary Artery Disease, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Article Synopsis
  • The study looked at the outcomes of patients undergoing percutaneous coronary intervention (PCI) for left main (LM) chronic total occlusions (CTO) compared to non-LM CTOs across multiple centers from 2012 to 2024.
  • Out of over 15,000 CTO PCIs, only 85 involved LM CTOs, which were associated with older patients who commonly had higher rates of health issues like heart failure and previous bypass surgeries.
  • Despite higher complications and angiographic complexity in LM CTO cases, the technical success rates were similar to non-LM PCIs, indicating that they can be performed safely despite their challenges.
View Article and Find Full Text PDF

Objective: This study was designed to investigate if artificial intelligence (AI) detection software can determine the use of AI in personal statements for residency applications.

Method: Previously written personal statements were collected from physicians who had already matched to residency through the Electronic Residency Application System. Physicians were recruited for the study through collegial relationships and were given study information via email.

View Article and Find Full Text PDF

Background: The J-CTO investigators recently developed angiographic difficulty scores for each of the three major coronary arteries in patients undergoing first-attempt chronic total occlusion (CTO) percutaneous coronary intervention (PCI) in de novo occlusions.

Methods: We examined the performance of the individual J-CTO scores in a large multicenter registry.

Results: The CTO lesion location was as follows: right coronary artery (RCA) 3,805 (54%), left anterior descending artery (LAD) 2,303 (33%), and left circumflex (LCX) 935 (13%).

View Article and Find Full Text PDF
Article Synopsis
  • - The TRILUMINATE Pivotal trial assessed the effects of tricuspid transcatheter edge-to-edge repair (T-TEER) on reducing tricuspid regurgitation (TR), a significant heart condition linked to increased health risks.
  • - Involving 572 patients, mostly elderly women with prior heart conditions, the trial found that T-TEER effectively improved quality of life, with nearly half of those treated experiencing significant improvements in heart health assessments.
  • - Results showed that while the treatment and control groups had similar rates of survival and heart-related surgeries, those who underwent T-TEER had notably better outcomes in TR severity and overall quality of life.
View Article and Find Full Text PDF

The impact of diabetes mellitus (DM) on the outcomes of bifurcation percutaneous coronary intervention (PCI) has received limited study. We compared the procedural characteristics and outcomes of patients with and without DM in 1,302 bifurcation PCIs (1,147 patients) performed at 5 centers between 2013 and 2024. The prevalence of DM was 33.

View Article and Find Full Text PDF

There are limited comparative data on the use of plaque modification devices during chronic total occlusion (CTO) percutaneous coronary intervention (PCI). We compared intravascular lithotripsy (IVL) with rotational atherectomy (RA) for lesion preparation in patients who underwent CTO PCI across 50 US and non-US centers from 2019 to 2024. Of 15,690 patients who underwent CTO PCI during the study period, 436 (2.

View Article and Find Full Text PDF

Incidence, Predictors, and Outcomes of Unplanned Coronary Angiography After Transcatheter Aortic Valve Replacement.

JACC Cardiovasc Interv

September 2024

Valve Science Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA; Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA. Electronic address:

Background: Assessment of coronary artery disease (CAD) is critical in managing severe aortic stenosis. Unplanned coronary angiography after TAVR, with or without percutaneous coronary intervention, may present significant challenges.

Objectives: The aim of this study was to evaluate the incidence, predictors, and outcomes of unplanned coronary angiography after transcatheter aortic valve replacement (TAVR).

View Article and Find Full Text PDF

Background: Understanding ascending aortic aneurysm growth and associated risk factors is critical to advising appropriate echocardiographic follow-up intervals for patients. The aim of this study was to identify aortic aneurysm growth rate on serial echocardiography as well as the clinical and demographic variables that contribute to baseline aortic size and subsequent aortic growth.

Methods: Patients identified with ascending aortic aneurysms and undergoing serial echocardiograms within 5 years were evaluated.

View Article and Find Full Text PDF

Three-Year Outcomes Following TAVR in Younger (<75 Years) Low-Surgical-Risk Severe Aortic Stenosis Patients.

Circ Cardiovasc Interv

November 2024

Department of Interventional Cardiology and Cardiothoracic Surgery, Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, TX (N.S.K., M.J.R.).

Article Synopsis
  • A study compared transcatheter aortic valve replacement (TAVR) with traditional surgery in low-risk patients under 75 years old with severe aortic stenosis to evaluate safety and effectiveness over three years.* -
  • Results showed that TAVR patients had similar overall mortality rates but significantly fewer disabling strokes (0.6%) compared to surgery patients (2.9%), while TAVR also resulted in better valve performance.* -
  • Both treatment options had comparable low rates of valve reinterventions, but TAVR patients experienced higher rates of pacemaker implantation (21.0% vs. 7.1%).*
View Article and Find Full Text PDF
Article Synopsis
  • Heart failure (HF) and aortic stenosis (AS) often occur together, complicating treatment due to their related effects on the heart’s function and high rates of serious outcomes.
  • Despite improvements in aortic valve replacement methods, HF is still a major reason patients are rehospitalized and is closely linked to higher mortality rates after surgery.
  • Understanding how HF develops in patients with AS involves studying heart changes caused by the valve's narrowing, the effects of valve replacement, and the role of other health conditions and biomarkers that indicate heart function and risk levels.
View Article and Find Full Text PDF

Atrial Mechanics, Atrial Cardiomyopathy and Impact of Atrial Interventions.

J Card Fail

October 2024

Division of Cardiology, Duke University Medical Center, Durham, NC, USA; Duke Clinical Research Institute, Durham, NC, USA; Department of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland. Electronic address:

Article Synopsis
  • Our understanding of how the atria (upper chambers of the heart) work and how they can become dysfunctional (atrial cardiomyopathy) has improved, especially regarding their impact on various heart conditions.
  • Different atrial medical procedures can affect the way the atria function, and it's important for healthcare professionals to be aware of potential negative effects that may not show up right away.
  • By identifying early signs of atrial dysfunction, clinicians can intervene sooner, potentially preventing serious changes in atrial structure and function before they lead to visible health issues.
View Article and Find Full Text PDF
Article Synopsis
  • A study analyzed the outcomes of chronic total occlusion (CTO) percutaneous coronary interventions (PCI) specifically in patients with anomalous coronary arteries (ACA) from a large dataset of over 14,000 patients between 2012 and 2023.
  • Among 14,470 CTO procedures, only 36 (0.24%) were performed on patients with ACA, who displayed similar baseline characteristics to those without ACA, but had more complicated lesions, requiring longer procedures and greater contrast volume.
  • Despite the increased complexity, ACA patients achieved similar procedural success rates to non-ACA patients, with no major adverse cardiac events reported in the ACA group, indicating a favorable outcome for CTO PCI in
View Article and Find Full Text PDF

Baroreflex Function in Cardiovascular Disease.

J Card Fail

January 2025

Division of Cardiology, Department of Medicine, Duke University, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina. Electronic address:

The baroreflex system is involved in modulating several physiological functions of the cardiovascular system and can modulate cardiac output, blood pressure, and cardiac electrophysiology directly and indirectly. In addition, it is involved in regulating neurohormonal pathways involved in the cardiovascular function, such as the renin-angiotensin-aldosterone system and vasopressin release. Baroreflex dysfunction is characterized by sympathetic overactivation and parasympathetic withdrawal and is associated with several cardiovascular diseases, such as hypertension, heart failure, and coronary artery disease.

View Article and Find Full Text PDF

The healthcare industry continues to experience high rates of burnout, turnover, and staffing shortages that erode quality care. Interventions that are feasible, engaging, and impactful are needed to improve cultures of support and mitigate harm from exposure to morally injurious events. This quality improvement project encompassed the methodical building, implementation, and testing of RECONN (Reflection and Connection), an organizational intervention designed by an interdisciplinary team to mitigate the impact of moral injury and to increase social support among nurses.

View Article and Find Full Text PDF

Objectives: Continuous, therapeutic anticoagulation is the standard of care for patients on extracorporeal membrane oxygenation (ECMO). The risks of hemorrhage exacerbated by anticoagulation must be weighed with the thrombotic risks associated with ECMO. We hypothesized increased thrombotic events in patients who had interrupted (vs.

View Article and Find Full Text PDF

Objectives: To evaluate outcomes of patients with complex aortic aneurysms (cAAs) undergoing fenestrated/branched endovascular aortic aneurysm repair (f/b-EVAR) using a combination of endoprostheses from different manufacturers.

Methods: The study is a 2-center retrospective analysis of prospectively maintained databases of patients with cAAs undergoing f/b-EVAR using a combination of endoprostheses from different manufacturers from 2013 to 2023. Primary endpoints included technical success, major adverse events and reintervention rates.

View Article and Find Full Text PDF
Article Synopsis
  • Coronary microvascular dysfunction (CMD) often occurs after ST-elevation myocardial infarction (STEMI) and can negatively impact patient outcomes; TMAO, a gut microbiota metabolite, may help diagnose CMD in these patients.
  • In a study involving 210 STEMI patients, TMAO levels were measured at various points, with a key finding being that TMAO at 3 months was a more reliable indicator for diagnosing CMD compared to baseline levels.
  • The research concluded that high TMAO levels (≥3.91) were linked to a greater risk of major adverse cardiovascular and cerebrovascular events (MACCE), highlighting TMAO's potential as a biomarker that could enhance
View Article and Find Full Text PDF